Literature DB >> 16724430

Chondroitin sulfate for interstitial cystitis.

E Palylyk-Colwell.   

Abstract

(1) Chondroitin sulfate solution 2.0% is a glycosaminoglycan (GAG) replenishment therapy instilled into the bladder of GAG-deficient patients with interstitial cystitis (IC). (2) Two non-randomized, uncontrolled pilot studies report improvements in patient-reported symptoms after the use of chondroitin sulfate for one year. Prospective, randomized, head-to-head trials are needed to assess the effectiveness of this technology compared with other IC therapies. (3) The cost and demand for this technology are low, but there could be a significant impact on clinics that administer treatment, if uptake increases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724430

Source DB:  PubMed          Journal:  Issues Emerg Health Technol        ISSN: 1488-6316


  3 in total

1.  Safety and efficacy of Intravesical hyaluronic acid/chondroitin sulfate in the treatment of refractory painful bladder syndrome.

Authors:  Hammouda Sherif; Ahmed Sebay; Wael Kandeel; Tarek Othman; Abdallah Fathi; Ahmed Mohey; Ali Eshazly
Journal:  Turk J Urol       Date:  2018-11-21

2.  Hyaluronan treatment of interstitial cystitis/painful bladder syndrome.

Authors:  Claus R Riedl; Paul F Engelhardt; Kurosch L Daha; Nike Morakis; Heinz Pflüger
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-12-21

3.  Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results.

Authors:  M Cervigni; F Natale; L Nasta; A Mako
Journal:  Int Urogynecol J       Date:  2012-05-09       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.